Last reviewed · How we verify
NCT04732130: LIMITFOOD
Monitoring During Different Intermittent Fasting Protocols in Non-Obese Adults
NA trial testing Time-Restricted Feeding in Intermittent Fasting in 76 participants. Completed in 1 July 2023.
1 July 2023
Quick facts
| Lead sponsor | Philipp Gerber |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 76 |
| Start date | 10 March 2021 |
| Primary completion | 1 July 2023 |
| Estimated completion | 1 July 2023 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Time-Restricted Feeding
- Alternate Day Fasting
Conditions studied
- Intermittent Fasting — all drugs for Intermittent Fasting →
- Overweight — all drugs for Overweight →
- Time Restricted Feeding — all drugs for Time Restricted Feeding →
Sponsor
Philipp Gerber
Who can join
Adults 18 to 40, any sex, with Intermittent Fasting or Overweight. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
LIMITFOOD is a randomized clinical intervention study that investigates the effects of two different intermittent fasting protocols compared to a control group on the health of normal- and overweight adults. A total of 72 participants will be randomized into three equally sized groups: an alternate day fasting, a time-restricted feeding and a control group.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Alternate-day fasting elicits larger changes in fat mass than time-restricted eating in adults without obesity - A randomized clinical trial.
Derron N, Güntner AT, Weber IC, Braun J, et al · · 2025 · cited 2× · PMID 40945487 · DOI 10.1016/j.clnu.2025.08.033
Verify or expand the search:
- PubMed search for NCT04732130
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Time-Restricted Feeding
Trials testing the same drug.
- NCT07505680 — Time-restricted Feeding and Health · NA · completed
- NCT05598515 — Time-restricted Feeding to Reduce Inflammation in Fanconi Anemia · NA · completed
- NCT04133701 — Meal Timing and Blood Pressure · NA · completed
- NCT04580433 — Time-restricted Feeding for Treating Polycystic Ovary Syndrome (PCOS) · NA · completed
- NCT06139562 — Two Different Dietary Approaches in Body Composition · NA · completed
Other recruiting trials for Intermittent Fasting
Currently open trials in the same condition.
- NCT06959069 — Impact of Intermittent Fasting on Sleep and Quality of Life · NA · recruiting
- NCT06330610 — Evaluation of the Efficiency of Intermittent Enteral Nutrition on Multi-organ Failure From Patients With Mechanical Vent · NA · recruiting
- NCT06546033 — Intermittent Fasting and Mediterranean Diet in Patient With Multiple Sclerosis · NA · recruiting
- NCT04899102 — Intermittent Fasting for NAFLD in Adults · NA · recruiting
- NCT04607096 — Intermittent Fasting to Improve Insulin Secretion · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04732130 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Philipp Gerber
- Last refreshed: 6 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04732130.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing